Latest news with #Prospectus
Yahoo
4 days ago
- Business
- Yahoo
AGI Announces Filing of Final Prospectus
The final short form prospectus is accessible through SEDAR+ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES WINNIPEG, Manitoba, June 04, 2025--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) ("AGI" or the "Company") is pleased to announce today that it has filed, and obtained a receipt for, a final short form prospectus (the "Prospectus") in each of the provinces of Canada, other than Québec, with respect to the previously announced bought deal offering of $85 million principal amount of 7.50% senior subordinated unsecured debentures (the "Offering") through a syndicate of underwriters (the "Underwriters") led by CIBC Capital Markets. The Company has also granted the Underwriters an option to purchase up to an additional $12.75 million aggregate principal amount of Debentures, on the same terms and conditions, exercisable in whole or in part, from time to time, up to 30 days following the closing of the Offering. Access to the Prospectus and any amendment thereto is provided in accordance with securities legislation relating to procedures for providing access to a prospectus and any amendment thereto. The Prospectus and any amendment thereto is accessible on SEDAR+ at An electronic or paper copy of the Prospectus and any amendment thereto may be obtained, without charge, by contacting CIBC Capital Markets at 161 Bay Street, 5th Floor, Toronto, ON M5J 2S8, by phone at (416) 956-6378 or by email at by providing the contact with an email address or address, as applicable. Prospective investors should read the Prospectus in its entirety before making an investment decision. The closing of the Offering is expected to occur on June 9, 2025, subject to customary closing conditions. AGI Company Profile AGI is a provider of the equipment and solutions required to support the efficient storage, transport, and processing of food globally. AGI has manufacturing facilities in Canada, the United States, Brazil, India, France, and Italy and distributes its product worldwide. This press release is not an offer of Debentures for sale in the United States. The Debentures may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, as amended, or an exemption from such registration. The Company has not registered and will not register the Debentures under the U.S. Securities Act of 1933, as amended. The Company does not intend to engage in a public offering of Debentures in the United States. This press release shall not constitute an offer to sell, nor shall there be any sale of, the Debentures in any jurisdiction in which such offer, solicitation or sale would be unlawful. FORWARD LOOKING STATEMENTS This press release contains certain forward–looking information and statements within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. In particular, but without limiting the forgoing, this press release contains statements concerning the over-allotment option and the closing date of the Offering. Although AGI believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them because AGI can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. The forward-looking statements contained in this press release are made as of the date hereof and AGI undertakes no obligations to update publicly or revise any forward looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. View source version on Contacts For More Information Contact: Andrew JacklinSr. Director, Investor Relations+1-437-335-1630investor-relations@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
4 days ago
- Business
- Business Wire
AGI Announces Filing of Final Prospectus
WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) ("AGI" or the "Company") is pleased to announce today that it has filed, and obtained a receipt for, a final short form prospectus (the "Prospectus") in each of the provinces of Canada, other than Québec, with respect to the previously announced bought deal offering of $85 million principal amount of 7.50% senior subordinated unsecured debentures (the "Offering") through a syndicate of underwriters (the "Underwriters") led by CIBC Capital Markets. The Company has also granted the Underwriters an option to purchase up to an additional $12.75 million aggregate principal amount of Debentures, on the same terms and conditions, exercisable in whole or in part, from time to time, up to 30 days following the closing of the Offering. Access to the Prospectus and any amendment thereto is provided in accordance with securities legislation relating to procedures for providing access to a prospectus and any amendment thereto. The Prospectus and any amendment thereto is accessible on SEDAR+ at An electronic or paper copy of the Prospectus and any amendment thereto may be obtained, without charge, by contacting CIBC Capital Markets at 161 Bay Street, 5th Floor, Toronto, ON M5J 2S8, by phone at (416) 956-6378 or by email at by providing the contact with an email address or address, as applicable. Prospective investors should read the Prospectus in its entirety before making an investment decision. The closing of the Offering is expected to occur on June 9, 2025, subject to customary closing conditions. AGI Company Profile AGI is a provider of the equipment and solutions required to support the efficient storage, transport, and processing of food globally. AGI has manufacturing facilities in Canada, the United States, Brazil, India, France, and Italy and distributes its product worldwide. This press release is not an offer of Debentures for sale in the United States. The Debentures may not be offered or sold in the United States absent registration under the U.S. Securities Act of 1933, as amended, or an exemption from such registration. The Company has not registered and will not register the Debentures under the U.S. Securities Act of 1933, as amended. The Company does not intend to engage in a public offering of Debentures in the United States. This press release shall not constitute an offer to sell, nor shall there be any sale of, the Debentures in any jurisdiction in which such offer, solicitation or sale would be unlawful. FORWARD LOOKING STATEMENTS This press release contains certain forward–looking information and statements within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. In particular, but without limiting the forgoing, this press release contains statements concerning the over-allotment option and the closing date of the Offering. Although AGI believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them because AGI can give no assurance that they will prove to be correct. Since forward looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. The forward-looking statements contained in this press release are made as of the date hereof and AGI undertakes no obligations to update publicly or revise any forward looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.
Yahoo
21-05-2025
- Business
- Yahoo
IDEX Biometrics ASA: Approved prospectus
Reference is made to the stock exchange announcements issued by IDEX Biometrics ASA (the "Company") on 11 March and 11 April 2025 regarding the successful loan financing of NOK 30 million and the subsequent conversion of such debt to shares in the Company at a subscription price of NOK 0.01 per share, resulting in the issuance of 3,000,000,000 new shares ("Debt Conversion' and 'Debt Conversion Shares"), the subsequent offering of up to 600,000,000 new shares at a subscription price equal to the subscription price in the Debt Conversion ("Subsequent Offering" and the "Offer Shares"), and the amendment of a certain senior convertible bond (the "Convertible Bond") issued by an affiliate of Heights Capital Management ("Heights") to the Company, whereby, among other things, the principal amount of the Convertible Bond was reduced to an aggregate principal amount of NOK 49,980,000. The listing of the Debt Conversion Shares, the Subsequent Offering and the listing of the Offer Shares remain subject to approval of a prospectus ("Prospectus") by the Financial Supervisory Authority of Norway ("FSA"), and the subsequent publication of such Prospectus by the Company. Further, the future listing of shares that may be issued by the Company upon conversion of the Convertible Bond (the conversion price currently being NOK 0.065, but which conversion price is subject to customary adjustment provisions) also remains subject to approval and publication of a Prospectus. The FSA has today approved the Prospectus. As a result of the above, the subscription period for the Subsequent Offering starts on 22 May 2025 and expires on 5 June 2025 at 16:30 CET. For further information on the Subsequent Offering, please refer to the Prospectus. Further, by reason of the approval and publication of the Prospectus, the Debt Conversion Shares will be transferred to the Company's ordinary ISIN and be admitted to trading on Oslo Børs. The Prospectus is enclosed with this announcement. It will also be available in electronic format at . Printed copies of the Prospectus may be obtained free of charge at the office of IDEX Biometrics ASA, Dronning Eufemias gate 16, NO-0191 Oslo, Norway, telephone +47 6783 9119 or by e-mail: companysecretary@ Arctic Securities AS acts as financial advisor and bookrunner in connection with the Subsequent Offering (the "Manager"). Ræder Bing advokatfirma AS acts as the Company's legal advisor. For further information, please contact: Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@ About IDEX Biometrics: IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit About this notice: This notice was issued by Kristian Flaten, CFO, on 21 May 2025 at 08:45 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12. Attachment 2025-05-21 Prospectus incl subscription form- IDEX Biometrics ASAError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-05-2025
- Business
- Yahoo
IDEX Biometrics ASA: Approved prospectus
Reference is made to the stock exchange announcements issued by IDEX Biometrics ASA (the "Company") on 11 March and 11 April 2025 regarding the successful loan financing of NOK 30 million and the subsequent conversion of such debt to shares in the Company at a subscription price of NOK 0.01 per share, resulting in the issuance of 3,000,000,000 new shares ("Debt Conversion' and 'Debt Conversion Shares"), the subsequent offering of up to 600,000,000 new shares at a subscription price equal to the subscription price in the Debt Conversion ("Subsequent Offering" and the "Offer Shares"), and the amendment of a certain senior convertible bond (the "Convertible Bond") issued by an affiliate of Heights Capital Management ("Heights") to the Company, whereby, among other things, the principal amount of the Convertible Bond was reduced to an aggregate principal amount of NOK 49,980,000. The listing of the Debt Conversion Shares, the Subsequent Offering and the listing of the Offer Shares remain subject to approval of a prospectus ("Prospectus") by the Financial Supervisory Authority of Norway ("FSA"), and the subsequent publication of such Prospectus by the Company. Further, the future listing of shares that may be issued by the Company upon conversion of the Convertible Bond (the conversion price currently being NOK 0.065, but which conversion price is subject to customary adjustment provisions) also remains subject to approval and publication of a Prospectus. The FSA has today approved the Prospectus. As a result of the above, the subscription period for the Subsequent Offering starts on 22 May 2025 and expires on 5 June 2025 at 16:30 CET. For further information on the Subsequent Offering, please refer to the Prospectus. Further, by reason of the approval and publication of the Prospectus, the Debt Conversion Shares will be transferred to the Company's ordinary ISIN and be admitted to trading on Oslo Børs. The Prospectus is enclosed with this announcement. It will also be available in electronic format at . Printed copies of the Prospectus may be obtained free of charge at the office of IDEX Biometrics ASA, Dronning Eufemias gate 16, NO-0191 Oslo, Norway, telephone +47 6783 9119 or by e-mail: companysecretary@ Arctic Securities AS acts as financial advisor and bookrunner in connection with the Subsequent Offering (the "Manager"). Ræder Bing advokatfirma AS acts as the Company's legal advisor. For further information, please contact: Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@ About IDEX Biometrics: IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market. For more information, visit About this notice: This notice was issued by Kristian Flaten, CFO, on 21 May 2025 at 08:45 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12. Attachment 2025-05-21 Prospectus incl subscription form- IDEX Biometrics ASA
Mint
20-05-2025
- Business
- Mint
Borana Weaves IPO: 10 key risks investors should know before subscribing to the ₹145 crore issue
Borana Weaves IPO has experienced an exceptional response on its first day of bidding, with retail investors driving the issue to be fully subscribed within just a few hours after it opened. The textile manufacturer's initial public offering consists entirely of a new issue of up to 67.08 lakh equity shares, according to the red herring prospectus. Borana Weaves IPO price band is set between ₹205 and ₹216 per share, aimed at raising ₹145 crore. The funds raised from the IPO will be used to cover the expenses of establishing a new manufacturing unit to enhance the production of grey fabric in Surat, Gujarat, as well as to meet additional working capital needs and for general corporate purposes. Reports indicate that Borana Weaves' Chairman and Managing Director, Mangilal Ambalal Borana, mentioned that they have significantly increased their manufacturing capabilities in the synthetic textile sector over recent years. The funds from the IPO will assist in expanding their production infrastructure and fulfilling their working capital requirements. This move is in line with their long-term strategy to scale operations while prioritizing product quality and operational efficiency. Beeline Capital Advisors serves as the book running lead manager, while KFin Technologies acts as the registrar for the offering. Borana Weaves IPO GMP today is +55. This indicates Borana Weaves share price was trading at a premium of ₹55 in the grey market, according to Borana Weaves IPO - Key Risks Here are some of the key risks listed by the company in its Red-Herring Prospectus (RHP): Any inability to secure the necessary approvals, licenses, or permits for the operation of Proposed Unit 4 could negatively impact the company's business, financial status, cash flow, and operational results. As of December 31, 2024, over 98% of the company's revenue comes from customers located in Gujarat, and there are no long-term agreements in place with these customers. Any alterations or cancellations of their purchase orders or their failure to accurately predict demand for the company's products could adversely affect its business, operational results, and financial health. The company has a brief operating history, having started its operations in 2020, and it may struggle to maintain its previous growth rates. The company sources its raw material, POY Yarn, from individuals within the Promoter Group. If this arrangement is terminated or if obligations under this agreement are not fulfilled, it could adversely affect the company's business, financial health, cash flow, and operational outcomes. The company engages in transactions with related parties as part of its regular business activities and cannot guarantee that these transactions will not negatively impact its operational results and financial condition. There is an ongoing legal issue involving one of their Independent Directors. A negative outcome in this matter could adversely affect their reputation, business operations, cash flow, and overall financial health. If they fail to accurately anticipate customer demands and manage their inventory levels effectively, it could negatively impact their operational results, financial stability, and cash flow. The company's business and the demand for their products depend on the success of their customers' offerings to end consumers; any decrease in demand for these end-products could adversely affect their business, operational results, cash flow, and financial health. The business is capital-intensive, and they may need significant financing to support their growth strategies and expansion efforts. Inability to secure additional funding could negatively impact their business, operational results, financial stability, and cash flow. Any delays or defaults in customer payments may lead to an increase in working capital requirements and/or a decrease in the company's profits, which would affect their operations and financial health. Also Read | Borana Weaves IPO: Check out 10 key things to know from RHP before investing
